Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saroglitazar Magnesium in Primary Biliary Cholangitis
NCT05133336Phase 3Completed
- Sponsor
- Zydus Therapeutics
- Start
- Apr 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of saroglitazar in primary biliary cholangitis (PBC), sponsored by Zydus Therapeutics. Started Apr 2022; status: completed.
02
Drugs
saroglitazar
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT05133336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05133336.